AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2012
Sep 5, 2012
30016_dirs_2012-09-05_93279c29-94da-4e5e-a880-3383226d2ad5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-08-31
Reporting Person: POLEWACZYK JAMES F (Corporate Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-31 | Common Stock | M | 2500 | $34.37 | Acquired | 8501 | Direct |
| 2012-08-31 | Common Stock | M | 1201 | $56.95 | Acquired | 9702 | Direct |
| 2012-08-31 | Common Stock | M | 1755 | $56.95 | Acquired | 11457 | Direct |
| 2012-08-31 | Common Stock | M | 3 | $34.37 | Acquired | 11460 | Direct |
| 2012-08-31 | Common Stock | S | 5459 | $95.0102 | Disposed | 6001 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-31 | Non-Qualified Stock Option (right to buy) | $34.37 | M | 2500 | Disposed | 2016-02-13 | Common Stock (2500) | Direct |
| 2012-08-31 | Non-Qualified Stock Option (right to buy) | $56.95 | M | 1201 | Disposed | 2015-02-13 | Common Stock (1201) | Direct |
| 2012-08-31 | Incentive Stock Option (right to buy) | $56.95 | M | 1755 | Disposed | 2015-02-13 | Common Stock (1755) | Direct |
| 2012-08-31 | Incentive Stock Option (right to buy) | $34.37 | M | 3 | Disposed | 2016-02-13 | Common Stock (3) | Direct |
Footnotes
F1: Includes 79 shares and 51 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 03/30/2012 and 06/30/2012, respectively.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $95.00 to $95.10, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F3: Grant of options to buy shares of common stock becomes exercisable as to 4,149 on 02/14/2010, 02/14/2011, 04/14/2012, 02/14/2013, and the remaining 1,241 shares on 02/14/2014.
F4: Grant of options to buy shares of common stock becomes exercisable as to 1,201 shares on 02/14/2009, 02/14/2010, 02/14/2011, 02/14/2012, and the remaining 1,200 shares on 02/14/2013.
F5: Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.
F6: Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2010, 02/14/2011, 02/14/2012, 02/14/2013, and the remaining 2,909 shares on 02/14/2014.